PEPTONIC medical AB (publ) (FRA:28L)

Market Cap	8.20M
Revenue (ttm)	1.42M
Net Income (ttm)	-4.43M
Shares Out	n/a
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0002 - 0.0002
Beta	n/a
RSI	39.38
Earnings Date	Feb 22, 2026

About PEPTONIC medical AB

PEPTONIC medical AB (publ), a pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health. It offers VagiVital, a hormone-free treatment for symptoms related to vaginal atrophy, such as pain during intercourse, burning, itching, and dryness, as well as moisturizing and an oil-based intimate wash. The company also provides lifestyle consumer products under the Lunette brand. PEPTONIC medical AB (publ) was incorporated in 2009 and is headquartered in Bromma, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2009
• Employees: 27
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 28L

Financial Performance

In 2024, PEPTONIC medical AB's revenue was 26.89 million, a decrease of -27.55% compared to the previous year's 37.12 million. Losses were -60.03 million, 40.9% more than in 2023.

Financial numbers in SEK